This website uses cookies to deliver to you the best experience possible on SITC CONNECT. By continuing to use this site, you are providing to us your consent to ensure you receive such an experience.
View our privacy policy to learn more.
OK
Join SITC
Renew
Make a Gift
Skip to main content (Press Enter).
Sign in
Skip auxiliary navigation (Press Enter).
Subscribe
Skip main navigation (Press Enter).
Toggle navigation
Educational & Scientific Programs
ConnectED
Cancer Immunotherapy Winter School
SITC Biotech Strategic Meeting at NYSE
Patient and Survivor Education and Resources
Workshops
Tumor Immune Microenvironment: A Holistic Approach
Surfaceome Virtual Workshop
Bispecific T cell Engagers Virtual Workshop
Cytokines in Cancer Immunotherapy Virtual Workshop
Annual Meeting & Pre-Conference Programs
40th Annual Meeting & Pre-Conference Programs
Past and Future Annual Meetings & Pre-Conference Programs
Collaborative Education Programs
SITC Biotech Virtual Programs
Spring Scientific
2025 Spring Scientific
Past and Future Spring Scientific Programs
Calendar of Events
Advances in Cancer Immunotherapy
SITC Biotech Initiative
SITC Neoadjuvant Initiatives
Webinars and Online Education
Advances in Cancer Immunotherapy (ACI) Webinars
SITC-NCI Computational IO Series
Definitions, End Points, and Clinical Trial Designs for Bladder Cancer
Expanding Access to Cellular and Bispecific Therapies
2024 Glyco-Immunology Webinar Series
Immune Exclusion Virtual Summit
Immunomodulation of ADCs Virtual Summit
Immunoprevention Virtual Summit
Increasing Access to IO: A Global Webinar Series
Intralesional Virtual Summit
Neoadjuvant Virtual Summit
Neuro Immuno-Oncology Virtual Summit
SITC Clinical Practice Guidelines Online Education
Targets for Cancer IO – A Deep Dive Series
Professional Development & Training
Certificate in Cancer Immunotherapy
Professional Interest Communities
Fellowships
Women in Cancer Immunotherapy Network (WIN)
Women in Cancer Immunotherapy Network 2025
Women in SITC Community
Early Career Scientist (ECS) Committee
Clinical Trials Training and Resources
SITC Clinical Immuno-Oncology Network (SCION) Workshop
Maximizing the Value of Phase III Trials in Immuno-Oncology
ICI-related Adverse Events Terminology Definitions
Definitions, End Points, and Clinical Trial Designs for Bladder Cancer
Intratumoral Immunotherapy Clinical Trial (IICT) Design
NCI Immunotherapy Fellowship
SITC Sparkathon
Sparkathon 2025
Support Sparkathon
Other Resources
Calendar of Events
Path to SITC Leadership
Publications & Guidelines
Journal for ImmunoTherapy of Cancer
About JITC
Become a Reviewer
For Authors
From the Editors
JITC Collections and Special Issues
SITC Immunotherapy Books
SITC's Guide to Managing Immunotherapy Toxicity Textbook
Cancer Immunotherapy Principles and Practice Textbook, 2nd Ed.
SITC Scientific Publications News
SITC Clinical Practice Guidelines
Clinical Practice Guidelines
Clinical Practice Guidelines Online Education
Clinical Practice Guidelines Mobile App
SITC Cancer Immunotherapy Guideline News
Patient Resource Guides
Access & Advocacy
Policy
Summits and Initiatives
Summits and Initiatives Overview
Essential Biomarkers Initiative
IO Surrogate Endpoints Initiative
IO Resistance Initiative
Release Criteria Initiative
Advocacy News
Global Immunotherapy Access
Patient & Survivor Education & Resources
Membership
Academy of Immuno-Oncology
About the Academy
Corporate Membership
Benefits, Categories & Application
Members Only
SITC Member Directory
Connect-a-Colleague
Volunteer
Volunteer with SITC
Support SITC
The Forward Fund
Moving the Field Forward
Making a Difference
Named Funds and Awards
Early Career Scientist Awards
Richard V. Smalley Memorial Award and Lectureship
Steven A. Rosenberg Scholars Award
Jeffrey S. Weber Memorial Fund
Technology Awards
Martin "Mac" Cheever Travel Award Fund
Sparkathon
The CheckPoints: SITC’s House Band
Ways to Make a Gift
Donate
Stocks and Securities
Estate and Planned Gifts
Corporate Support and Giving Opportunities
Corporate Giving Opportunities
Corporate Membership
Educational Grants
Sponsorship & Advertising
SITC Merchandise
Honor and Memorial Gifts
Make a Gift in Honor of a Loved One
Make a Gift in Memory of a Loved One
Our Donors and Supporters
2022 SITC Supporters
Forward
Fund Donors
About SITC
Strategic Plan
Awards and Recognition
Career Connections
SITC’s DEI Strategy
Elevating a Rich Oncology Community: SITC’s DEI Strategic Plan
Virtual Roundtable on Diversity in Clinical Trial Enrollment
Media Room
SITC Press Releases
Scientific Meeting Highlights from SITC
Immune Monitor Archive
JITC Digest Archive
Cancer Immunotherapy Month
SITC Policies
SITC Biotech Initiative
Board of Directors
Committees, Task Forces and Professional Interest Communities
Mission & Vision
Contact SITC
The Connect Community
Create Account
My Profile
My Communities
My Libraries
The Sentinel - SITC Blog
SITC Guidelines News Community Blog
Call for Comment: SITC Renal Cell Carcinoma CPG v3.0 Until May 8
posted
13 hours ago
0
Like
Manuscript Title: Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of renal cell carcinoma v3.0 Draft Manuscript Summary The Society for Immunotherapy ...
0 comments
Lymphoma CPG Update V1.4 Now Available
posted
29 days ago
0
Like
An update to " Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma ” is now available. In accordance with the Institute of Medicine’s Standards for Developing ...
0 comments
Melanoma CPG Addendum v3.2 Now Available
posted
03-18-2025
0
Like
An addendum to the " Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma " is now available. In accordance with the Institute of Medicine’s Standards for ...
0 comments
Apply to Join the Cancer Immunotherapy Guidelines Oversight Committee
posted
02-26-2025
0
Like
The Society for Immunotherapy of Cancer (SITC) is seeking volunteers to join the Cancer Immunotherapy Guidelines (CIG) Oversight Committee, which plays a key role in guiding the society’s clinical practice guideline development ...
0 comments
Head and Neck Squamous Cell Carcinoma CPG Update v1.1 Now Available
posted
11-18-2024
0
Like
An update to " Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of head and neck squamous cell carcinoma ” is now available. In accordance with the Institute of ...
0 comments
Urothelial Cancer CPG Update v2.4 Now Available
posted
11-01-2024
0
Like
An update to " Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer " is now available. In accordance with the Institute of Medicine’s Standards ...
0 comments
User-Generated
SITCGuidelines
SITC CPG Mobile App Receives 2024 President's Award from the American Association of Medical Society Executives
posted
08-06-2024
1
Like
The Society for Immunotherapy of Cancer (SITC) is pleased to announce that the SITC Clinical Practice Guidelines (CPG) Mobile App has been selected by the American Association of Medical Society Executives (AAMSE) to receive ...
0 comments
ICI-Related Adverse Events CPG Updates v1.1 and v1.2 Now Available
posted
07-18-2024
1
Like
In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs), SITC CPGs undergo periodic evaluation to assess if new evidence necessitates modifications to recommendations, ...
0 comments
Urothelial Cancer CPG Update v2.3 Now Available
posted
07-12-2024
1
Like
In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs), SITC CPGs undergo periodic evaluation to assess if new evidence necessitates modifications to recommendations, ...
0 comments
Melanoma CPG Update v3.1 Now Available
posted
06-27-2024
1
Like
In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs), SITC CPGs undergo periodic evaluation to assess if new evidence necessitates modifications to recommendations, ...
0 comments
Gynecologic Cancer CPG Update v1.1 Now Available
posted
06-20-2024
1
Like
In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs), SITC CPGs undergo periodic evaluation to assess if new evidence necessitates modifications to recommendations, ...
0 comments
Breast Cancer CPG Update v1.2 Now Available
posted
06-03-2024
2
Like
In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs), SITC CPGs undergo periodic evaluation to assess if new evidence necessitates modifications to recommendations, ...
0 comments
SITC Living Guidelines – Rapid Updates to Published Clinical Practice Guidelines
posted
05-23-2024
1
Like
In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs), SITC CPGs undergo periodic evaluation to assess if new evidence necessitates modifications to recommendations, ...
0 comments
Nonmelanoma Skin Cancer CPG Update v1.1 Now Available
posted
03-19-2024
1
Like
In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs), SITC CPGs undergo periodic evaluation to assess if new evidence necessitates modifications to recommendations, ...
0 comments
New SITC Melanoma CPG Published in JITC
posted
10-18-2023
1
Like
On behalf of the Society for Immunotherapy of Cancer (SITC) and the SITC Melanoma Guideline Expert Panel, we are pleased to announce the publication of SITC’s Melanoma Clinical Practice Guideline (CPG), version 3.0. This ...
0 comments
New SITC Gynecologic Cancer CPG Published in JITC
posted
06-09-2023
1
Like
On behalf of the Society for Immunotherapy of Cancer (SITC) and the SITC Gynecologic Cancer Immunotherapy Guideline Expert Panel, we are pleased to announce the publication of SITC’s Gynecologic Cancer Clinical Practice ...
0 comments
New SITC Gastrointestinal Cancer CPG Published in JITC
posted
06-07-2023
0
Like
SITC is pleased to announce the publication of our newest guideline, " Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer. " Clinicians ...
0 comments
Open Comment Period for SITC’s Melanoma Guideline Closes March 16
posted
02-23-2023
1
Like
The Society for Immunotherapy of Cancer (SITC) Melanoma Immunotherapy Guideline Expert Panel is pleased to invite public comment on the draft clinical practice guideline (CPG) “Society for Immunotherapy of Cancer (SITC) clinical ...
0 comments
Open Comment Periods for SITC’s Gynecologic Cancer and Gastrointestinal Cancer Guidelines Close January 27
posted
01-12-2023
0
Like
The Society for Immunotherapy of Cancer (SITC) is pleased to invite public comment on two new draft clinical practice guidelines (CPGs): “Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy ...
0 comments
Help SITC Performance Test Our Next Quality Measure – Apply by January 5
posted
12-20-2022
1
Like
The Society for Immunotherapy of Cancer (SITC) is currently recruiting practices for clinician-level testing of the draft quality measure: Positive PD-L1 Biomarker Expression Test Result Prior to First-Line Immune Checkpoint ...
0 comments
«
1
2
»
Back to SITC Cancer Immunotherapy Guidelines
Membership Links
Join
Renew
Member Directory
My Profile
Get Involved
Email Sign-up
Volunteer
Support SITC
Contact Us
© 2025 Society for Immunotherapy of Cancer (SITC). All rights reserved.
Powered by Higher Logic